Home › Products › Neurology › Edarabid 1.5mg Injection
Edarabid 1.5mg Injection
Salt Composition: EDARAVONE
- Manufacturer: INTAS PHARMACEUTICALS LTD
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 1.5MG
- Prescription Required
- Storage: Store at controlled room temperature, between 20°C to 25°C (68°F to 77°F). Keep away from moisture, heat, and light. Do not freeze. Keep out of reach of children and pets.
₹398.00₹497.81
Inclusive of all taxes
Product Introduction
Edarabid 1.5mg Injection is a medication indicated for critical neurological conditions including amyotrophic lateral sclerosis (ALS) and acute ischemic stroke. ALS is a progressive neurodegenerative disease affecting the motor neurons responsible for controlling voluntary muscle movement, resulting in muscle weakness, paralysis, and eventual respiratory failure. Acute ischemic stroke, caused by sudden blockage of blood flow to the brain, can cause significant neurological impairment including loss of mobility and speech difficulties. Edarabid 1.5mg Injection is used to slow disease progression in ALS and improve post-stroke neurological recovery. The active ingredient, Edaravone, reduces oxidative stress—a key factor in neuronal damage in both ALS and stroke. By functioning as a free radical scavenger, Edaravone protects nerve cells from oxidative damage, slowing ALS progression and improving recovery outcomes in stroke patients.
Uses
Edarabid injection uses to treat amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative condition that affects nerve cells in the brain and spinal cord, leading to muscle weakness and loss of motor control. It is also prescribed to manage neurological impairments caused by acute ischemic stroke, helping to reduce the extent of brain damage and improve functional recovery.
How it works
Edarabid 1.5mg Injection contains Edaravone, which acts as a free radical scavenger. During conditions like ALS and stroke, oxidative stress causes damage to neurons and other cells. Edaravone neutralizes harmful free radicals, thereby protecting nerve cells from further damage. This action slows the progression of ALS and minimizes brain damage after a stroke, improving overall neurological outcomes.
How to Use
Inform your doctor about any pre-existing medical conditions or allergies before starting this medication.
Side Effects
It’s crucial to monitor patients closely during treatment of edaravone infusion and report any unusual symptoms to a healthcare provider immediately. Some of the commonly reported edaravone infusion side effects include Common Side Effects: Bruising Walking difficulties Headache Injection site reactions (pain, swelling, redness) Severe Side Effects: Hypersensitivity reactions, including swelling of the lips, tongue, or face Difficulty breathing or wheezing Severe dizziness or fainting Hives or intense itching Anaphylactic reactions Increased liver enzyme levels (indicating liver injury)
References
- https://go.drugbank.com/drugs/DB12243
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5737249/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5735759/
Safety Advice
Pregnancy: unsafe Edarabid 1.5mg Injection may be unsafe to use during pregnancy. Animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and potential risks before prescribing it to you. Please consult your doctor.
Lungs: Consult your doctor Use with caution in individuals with lung diseases, as Edaravone is eliminated primarily via the kidneys. Dosage adjustments may be required.
Breastfeeding: Consult your doctor Information regarding the use of Edarabid 1.5mg Injection during breastfeeding is not available. Please consult your doctor.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.